Troubles liés aux opiacés : Questions médicales fréquentes
Nom anglais: Opioid-Related Disorders
Descriptor UI:D009293
Tree Number:F03.900.647.500
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Troubles liés aux opiacés : Questions médicales les plus fréquentes",
"headline": "Troubles liés aux opiacés : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Troubles liés aux opiacés : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-06",
"dateModified": "2025-05-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Troubles liés aux opiacés"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Troubles liés à l'usage de substances psychotropes",
"url": "https://questionsmedicales.fr/mesh/D000079524",
"about": {
"@type": "MedicalCondition",
"name": "Troubles liés à l'usage de substances psychotropes",
"code": {
"@type": "MedicalCode",
"code": "D000079524",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.900.647"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dépendance à l'héroïne",
"alternateName": "Heroin Dependence",
"url": "https://questionsmedicales.fr/mesh/D006556",
"about": {
"@type": "MedicalCondition",
"name": "Dépendance à l'héroïne",
"code": {
"@type": "MedicalCode",
"code": "D006556",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.900.647.500.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dépendance à la morphine",
"alternateName": "Morphine Dependence",
"url": "https://questionsmedicales.fr/mesh/D009021",
"about": {
"@type": "MedicalCondition",
"name": "Dépendance à la morphine",
"code": {
"@type": "MedicalCode",
"code": "D009021",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.900.647.500.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Surdose d'opiacés",
"alternateName": "Opiate Overdose",
"url": "https://questionsmedicales.fr/mesh/D000083682",
"about": {
"@type": "MedicalCondition",
"name": "Surdose d'opiacés",
"code": {
"@type": "MedicalCode",
"code": "D000083682",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.900.647.500.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dépendance à l'opium",
"alternateName": "Opium Dependence",
"url": "https://questionsmedicales.fr/mesh/D000074607",
"about": {
"@type": "MedicalCondition",
"name": "Dépendance à l'opium",
"code": {
"@type": "MedicalCode",
"code": "D000074607",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.900.647.500.800"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Troubles liés aux opiacés",
"alternateName": "Opioid-Related Disorders",
"code": {
"@type": "MedicalCode",
"code": "D009293",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sharon L Walsh",
"url": "https://questionsmedicales.fr/author/Sharon%20L%20Walsh",
"affiliation": {
"@type": "Organization",
"name": "Department of Behavioral Science, College of Medicine, University of Kentucky, Lexington, KT, USA."
}
},
{
"@type": "Person",
"name": "Michelle R Lofwall",
"url": "https://questionsmedicales.fr/author/Michelle%20R%20Lofwall",
"affiliation": {
"@type": "Organization",
"name": "Center on Drug and Alcohol Research, University of Kentucky, Lexington."
}
},
{
"@type": "Person",
"name": "Kevin Y Xu",
"url": "https://questionsmedicales.fr/author/Kevin%20Y%20Xu",
"affiliation": {
"@type": "Organization",
"name": "Health and Behavior Research Center, Department of Psychiatry, Washington University School of Medicine in St Louis, St Louis, Missouri."
}
},
{
"@type": "Person",
"name": "Richard A Grucza",
"url": "https://questionsmedicales.fr/author/Richard%20A%20Grucza",
"affiliation": {
"@type": "Organization",
"name": "Health and Behavior Research Center, Department of Psychiatry, Washington University School of Medicine in St Louis, St Louis, Missouri."
}
},
{
"@type": "Person",
"name": "Elizabeth E Krans",
"url": "https://questionsmedicales.fr/author/Elizabeth%20E%20Krans",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh School of Medicine, Magee-Womens Research Institute, 300 Halket Street, Pittsburgh, PA 15213, USA. Electronic address: kransee@upmc.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Opioid use disorder in cancer patients.",
"datePublished": "2023-03-03",
"url": "https://questionsmedicales.fr/article/36866646",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/SPC.0000000000000640"
}
},
{
"@type": "ScholarlyArticle",
"name": "Exploring the Barriers to Buprenorphine Therapy for Cancer-Related Pain and Concurrent Opioid Use Disorder: A Case Report.",
"datePublished": "2022-07-20",
"url": "https://questionsmedicales.fr/article/35861726",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1089/jpm.2022.0182"
}
},
{
"@type": "ScholarlyArticle",
"name": "Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting.",
"datePublished": "2022-07-22",
"url": "https://questionsmedicales.fr/article/35837678",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/21548331.2022.2102776"
}
},
{
"@type": "ScholarlyArticle",
"name": "The association of chronic pain and opioid withdrawal in men and women with opioid use disorder.",
"datePublished": "2022-09-14",
"url": "https://questionsmedicales.fr/article/36126611",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.drugalcdep.2022.109631"
}
},
{
"@type": "ScholarlyArticle",
"name": "Beyond the Syndemic of Opioid Use Disorders and HIV: The Impact of Opioids on Viral Reservoirs.",
"datePublished": "2023-08-09",
"url": "https://questionsmedicales.fr/article/37632053",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/v15081712"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Troubles mentaux",
"item": "https://questionsmedicales.fr/mesh/D001523"
},
{
"@type": "ListItem",
"position": 3,
"name": "Troubles liés à une substance",
"item": "https://questionsmedicales.fr/mesh/D019966"
},
{
"@type": "ListItem",
"position": 4,
"name": "Troubles liés à l'usage de substances psychotropes",
"item": "https://questionsmedicales.fr/mesh/D000079524"
},
{
"@type": "ListItem",
"position": 5,
"name": "Troubles liés aux opiacés",
"item": "https://questionsmedicales.fr/mesh/D009293"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Troubles liés aux opiacés - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Troubles liés aux opiacés",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Troubles liés aux opiacés",
"description": "Comment diagnostiquer un trouble lié aux opiacés ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels critères DSM sont utilisés pour le diagnostic ?\nQui peut poser le diagnostic ?\nLe diagnostic peut-il être fait à distance ?",
"url": "https://questionsmedicales.fr/mesh/D009293?page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Troubles liés aux opiacés",
"description": "Quels sont les symptômes courants des troubles liés aux opiacés ?\nComment se manifeste le sevrage des opiacés ?\nLes troubles cognitifs sont-ils fréquents ?\nY a-t-il des symptômes physiques associés ?\nLes symptômes varient-ils selon les individus ?",
"url": "https://questionsmedicales.fr/mesh/D009293?page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Troubles liés aux opiacés",
"description": "Comment prévenir les troubles liés aux opiacés ?\nLes programmes scolaires aident-ils à la prévention ?\nQuel rôle jouent les médecins dans la prévention ?\nLes campagnes de sensibilisation sont-elles efficaces ?\nComment les familles peuvent-elles aider à prévenir ?",
"url": "https://questionsmedicales.fr/mesh/D009293?page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Troubles liés aux opiacés",
"description": "Quels traitements sont disponibles pour les troubles liés aux opiacés ?\nQu'est-ce que la méthadone ?\nComment fonctionne la buprénorphine ?\nLa thérapie de groupe est-elle efficace ?\nQuels sont les effets des traitements médicamenteux ?",
"url": "https://questionsmedicales.fr/mesh/D009293?page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Troubles liés aux opiacés",
"description": "Quelles sont les complications des troubles liés aux opiacés ?\nComment les overdoses se produisent-elles ?\nLes troubles cardiaques sont-ils une complication ?\nLes infections sont-elles un risque ?\nLes troubles respiratoires peuvent-ils survenir ?",
"url": "https://questionsmedicales.fr/mesh/D009293?page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Troubles liés aux opiacés",
"description": "Quels sont les facteurs de risque des troubles liés aux opiacés ?\nL'âge influence-t-il le risque ?\nLes antécédents de traumatismes augmentent-ils le risque ?\nLe stress est-il un facteur de risque ?\nLes prescriptions médicales abusives sont-elles un risque ?",
"url": "https://questionsmedicales.fr/mesh/D009293?page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un trouble lié aux opiacés ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des critères cliniques, l'historique d'usage et des évaluations psychologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de dépistage de drogues et des évaluations psychologiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels critères DSM sont utilisés pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le DSM-5 utilise des critères spécifiques comme la tolérance et le sevrage pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Qui peut poser le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un professionnel de santé qualifié, comme un médecin ou un psychologue, peut poser le diagnostic."
}
},
{
"@type": "Question",
"name": "Le diagnostic peut-il être fait à distance ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des consultations à distance peuvent aider à évaluer les symptômes et poser un diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des troubles liés aux opiacés ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'anxiété, la dépression, des troubles de l'humeur et des problèmes physiques."
}
},
{
"@type": "Question",
"name": "Comment se manifeste le sevrage des opiacés ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le sevrage peut provoquer des douleurs, des nausées, des tremblements et des troubles du sommeil."
}
},
{
"@type": "Question",
"name": "Les troubles cognitifs sont-ils fréquents ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la mémoire et de la concentration sont souvent observés chez les utilisateurs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes physiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la constipation, la fatigue et des douleurs corporelles peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les individus ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de la durée et de la quantité d'usage d'opiacés."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés aux opiacés ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'éducation, la sensibilisation et l'accès à des soins de santé appropriés."
}
},
{
"@type": "Question",
"name": "Les programmes scolaires aident-ils à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les programmes éducatifs en milieu scolaire peuvent réduire l'usage d'opiacés chez les jeunes."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les médecins dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les médecins peuvent sensibiliser les patients aux risques liés à l'usage d'opiacés et prescrire judicieusement."
}
},
{
"@type": "Question",
"name": "Les campagnes de sensibilisation sont-elles efficaces ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles augmentent la conscience des dangers des opiacés et encouragent des comportements sains."
}
},
{
"@type": "Question",
"name": "Comment les familles peuvent-elles aider à prévenir ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les familles peuvent soutenir la communication ouverte et surveiller les comportements à risque."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles liés aux opiacés ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie comportementale, la médication et le soutien psychosocial."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la méthadone ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La méthadone est un agoniste opioïde utilisé pour traiter la dépendance aux opiacés."
}
},
{
"@type": "Question",
"name": "Comment fonctionne la buprénorphine ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La buprénorphine est un agoniste partiel qui aide à réduire les symptômes de sevrage."
}
},
{
"@type": "Question",
"name": "La thérapie de groupe est-elle efficace ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie de groupe offre un soutien et des stratégies de coping aux personnes dépendantes."
}
},
{
"@type": "Question",
"name": "Quels sont les effets des traitements médicamenteux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements médicamenteux peuvent réduire les cravings et les symptômes de sevrage."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications des troubles liés aux opiacés ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des problèmes de santé mentale, des maladies infectieuses et des overdoses."
}
},
{
"@type": "Question",
"name": "Comment les overdoses se produisent-elles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les overdoses surviennent souvent par une consommation excessive ou une combinaison avec d'autres substances."
}
},
{
"@type": "Question",
"name": "Les troubles cardiaques sont-ils une complication ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'usage d'opiacés peut entraîner des problèmes cardiaques et des troubles circulatoires."
}
},
{
"@type": "Question",
"name": "Les infections sont-elles un risque ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les utilisateurs d'opiacés injectables sont à risque accru d'infections comme l'hépatite."
}
},
{
"@type": "Question",
"name": "Les troubles respiratoires peuvent-ils survenir ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les opiacés peuvent provoquer des dépressions respiratoires, mettant la vie en danger."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque des troubles liés aux opiacés ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des troubles mentaux et l'accès facile aux opiacés."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes adultes et les adolescents sont particulièrement vulnérables aux troubles liés aux opiacés."
}
},
{
"@type": "Question",
"name": "Les antécédents de traumatismes augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes ayant subi des traumatismes sont plus susceptibles de développer des troubles liés aux opiacés."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut augmenter la probabilité de développer une dépendance aux opiacés."
}
},
{
"@type": "Question",
"name": "Les prescriptions médicales abusives sont-elles un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des prescriptions inappropriées ou excessives d'opiacés augmentent le risque de dépendance."
}
}
]
}
]
}
The misuse of opioids has increased significantly in recent decades. Historically, cancer patients have not been considered at risk of opioid misuse. However, cancer pain is common, and opioids are of...
Early cancer diagnoses and treatments have improved cancer survival rates, leading to a larger population of cancer patients and survivors. Opioid use disorder (OUD) may precede a cancer diagnosis or ...
OUD in cancer patients has only relatively recently been recognised as a growing problem. Early identification, involvement of the multidisciplinary team, and treatment can reduce the negative impact ...
Although buprenorphine is widely accepted as a treatment option for opioid use disorder (OUD), it is underutilized as a treatment for cancer-related pain. Owing to its decreased side effect profile, v...
Opioid use disorder (OUD) has become increasingly prevalent among hospitalized patients in the United States and globally. As its prevalence increases, this provides a valuable opportunity for clinici...
This article aims to provide hospitalists and other clinicians working in the hospital with a narrative review of the management of opioid withdrawal and the initiation of medications for opioid use d...
Authors performed a narrative review of the literature....
Management can initially include treating withdrawal symptoms with opioids as well as with a combination of non-opioid medications such as alpha 2 agonists, benzodiazepines, and/or antiemetics as need...
Proper management of opioid withdrawal and initiation of MOUD in the hospital can improve outcomes in patients with OUD....
Approximately 2.7 million individuals in the United States had an opioid use disorder (OUD) in 2020. Chronic pain may exacerbate opioid withdrawal severity, yet most research on opioid withdrawal has ...
Data were collected from N = 1252 individuals with OUD entering eight residential addiction treatment facilities. Demographic, drug use behaviors, and chronic pain status were collected at treatment i...
At intake, withdrawal was higher in persons who were older, had greater SUD severity, women, had chronic pain, and used > 1 substance (p-values ≤.007) and craving was higher in persons with greater SU...
Women and persons with chronic pain would benefit from earlier engagement in treatment and may require a more intensive strategy to mitigate opioid withdrawal in early treatment....
People with HIV are more likely to have opioid use disorder and to be prescribed opioids for chronic pain than the general population; however, the effects of opioids on the immune system and HIV pers...
Uncertainty remains about the longer-term benefits and harms of different opioid management strategies, such as tapering and dose escalation. For instance, opioid tapering could help patients reduce o...
To evaluate the association between opioid dose trajectories observed in practice and patient outcomes....
This retrospective cohort study was conducted in 3 health systems in Colorado and Wisconsin. The study population included patients receiving long-term opioid therapy between 50 and 200 morphine milli...
Group-based trajectory modeling identified 5 dosing trajectories over 1 year: 1 decreasing, 1 high-dose increasing, and 3 stable....
Primary outcomes assessed after the trajectory period were 1-year all-cause mortality, incident opioid use disorder, continued opioid therapy at 1 year, and health plan disenrollment. Associations wer...
A total of 3913 patients (mean [SD] age, 59.2 [14.4] years; 2767 White non-Hispanic [70.7%]; 2237 female patients [57.2%]) were included in the study. Compared with stable trajectories, the decreasing...
In this cohort study, decreasing opioid dose was associated with reduced risk of opioid use disorder and continued opioid therapy but increased risk of disenrollment compared with stable dosing, where...
The use of opioids is increasing globally, but data from low- and middle-income countries on opioid-related mental and behavioural disorders (hereafter referred to as opioid-related disorders) are sca...
We analysed longitudinal data of beneficiaries (≥ 11 years) of a South African medical insurance scheme using reimbursement claims from Jan 1, 2011, to Jul 1, 2020. Beneficiaries were classified as ha...
Of 1,251,458 beneficiaries, 1286 (0.1%) had opioid-related disorders. Between 2011 and 2020, the incidence of opioid-related disorders increased by 12% (95% CI 9%-15%) per year. Men, young adults in t...
The incidence of people diagnosed with or treated for an opioid-related disorder in the private sector is increasing rapidly. People with opioid-related disorders are a vulnerable population with subs...
BACKGROUND\OBJECTIVES: Concomitant with low rates of pharmacotherapy for incarcerated individuals with OUD, there is a high rate of opioid overdose following re-entry into the community. Our research ...
Secondary longitudinal analysis of data from a clinical trial where participants were randomized 1:1 to pre-release extended-release naltrexone (XR-NTX) + referral to community XR-NTX, vs. referral on...
Greater severity in the psychiatric composite score was associated with substantially lower HRQoL, across all measures, following release from incarceration. Greater severity in the medical composite ...
Our findings highlight the importance of ensuring individuals with OUD are linked not only to MOUD, but also treatment for their comorbid conditions upon release from incarceration....
Fibromyalgia and opioid use disorder (OUD) are highly impactful chronic illnesses with substantially overlapping psychosocial, biological, and clinical features. Little previous research has examined ...
Opioid use disorder (OUD) is a chronic relapsing disorder with a problematic pattern of opioid use, affecting nearly 27 million people worldwide. Machine learning (ML)-based prediction of OUD may lead...
We present an ensemble machine-learning model trained on a cross-linked Canadian administrative health data set from 2014 to 2018 (...
With 6409 OUD cases in 2019 (mean [SD], 45.34 [14.28], 3400 males), our model prospectively predicted OUD cases at a high accuracy (balanced accuracy, 86%, sensitivity, 93%; specificity 79%). In accor...
Our study presents an individualized prospective prediction of OUD cases by applying ML to large administrative health datasets. Such prospective predictions based on ML would be essential for potenti...